Risk Minimization Activities of Centrally Authorized Products in the EU

A Pregnancy-Prevention Program in Women of Childbearing Age Receiving Isotretinoin

Allen A. Mitchell, Carla M. Van Bennekom, Carol Louik · New England Journal of Medicine · 1995 · 182 citations · Full text

Medicine, Dermatology, Preventive Medicine +7

Benefits and Risks of Drug Treatments

Jan P. Vandenbroucke, Bruce M. Psaty · JAMA · 2008 · 129 citations

Pharmacy, Pharmaceutical Policy, Pharmacology +15

The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system

Janet Shin, T. Craig Cheetham, Linda L. Wong et al. · Journal of the American Academy of Dermatology · 2011 · 115 citations

Medicine, Obstetrics, Pharmacology +16

Ischemic Colitis and Complications of Constipation Associated With the Use of Alosetron Under a Risk Management Plan: Clinical Characteristics, Outcomes, and Incidences

Lin Chang, Kenneth Tong, Vanessa Z. Ameen · The American Journal of Gastroenterology · 2010 · 82 citations

Medicine, Internal Medicine, Pharmacotherapy +17

Trends in Adherence to a Revised Risk Management Program Designed to Decrease or Eliminate Isotretinoin-Exposed Pregnancies

Allen Brinker, Cynthia Kornegay, Parivash Nourjah · Archives of Dermatology · 2005 · 67 citations

Pharmacy, Clinical Pharmacy, Pharmacy Practice +15